Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol

Ian Hann(Royal Hospital for Children), Sue Richards(Oregon Health & Science University), Brenda Gibson(Royal Hospital for Children), Ajay Vora(Great Ormond Street Hospital), Frank G. H. Hill(Children's of Alabama), G Harrison, Osborn B. Eden, Christine J. Harrison(Newcastle University)

British Journal of Haematology

April 1, 2001

10.1046/j.1365-2141.2001.02668.x

Cited by 135

Related Papers

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

|Blood|2006|746

Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel

|Blood|2012|575

Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia

|Blood|2009|494

Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial

|Journal of Clinical Oncology|2013|415

Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia

|Journal of Clinical Oncology|2015|383